CTOs on the Move

Orbus Therapeutics

www.orbustherapeutics.com

 
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Orbus Therapeutics raised $18M on 08/21/2015

Similar Companies

Pioneer Medical Group

Pioneer Medical Group is a leader in the Hospitalist movement, providing the highest level of Hospital Medicine and Post Transition Care to Florida Hospitals in the West and Central Florida Region.

OLLY PBC

At OLLY, we believe happiness is an inside job. We know that the right blend of nutrients can help us stay strong, balanced and energetic.

DR Management

DR Management LLC is a Fort Wayne, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Graham Hospital

Graham Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Graham Hospital is based in Canton, IL. You can find more information on Graham Hospital at www.grahamhospital.org

EmpiRx Health

EmpiRx Health is challenging the status quo in today`s pharmacy benefit management industry by offering evidence-based clinical care programs that are aligned with our member`s needs. Our concierge model along with our proactive oversight and agile technology platform provide actionable insight to protect our clients and their members from ever-rising drug costs.